Low-Dose BCMA CAR-T Therapy Anito-Cel Eradicates Myeloma in All 38 Phase 1 Patients
A phase 1 trial found that the investigational BCMA-targeted CAR-T therapy anito-cel produced responses in all 38 participants with relapsed ...
A phase 1 trial found that the investigational BCMA-targeted CAR-T therapy anito-cel produced responses in all 38 participants with relapsed ...
An international team of experts argues in The Lancet Neurology that traumatic brain and spinal cord injuries should be managed ...
A mechanistic model from Mass General Brigham and the University of Cyprus shows how normalizing the tumor microenvironment, without over-tightening ...
A Mass General Brigham study of malignant ascites has identified rare RORC-expressing dendritic cells that may promote immune tolerance in ...
Mass General Brigham researchers report in Nature Aging that moderate exercise enriches blood-borne extracellular vesicles with microRNA-29, a signal that ...
A Mass General Brigham study found that adults receiving free weekly plant-based grocery packages for an average of 2.7 years ...
The 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans has become a significant platform ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine